
ArtMajeur by YourArt: a Merger Boosted by AI
Only six months after Artmajeur was acquired by Maurice Lévy, founder of YourArt, and with the total merging of all operations, the new ArtMajeur by YourArt platform is now equipped to become the favoured destination for artists, galleries, collectors, and all art lovers. Operating in 78 countries including France, the USA, England and Japan, its enormous scope makes it a vital player in the global online art market.
ArtMajeur by YourArt brings together the best of two entities. The power and impact of Artmajeur means that it attracts almost 800,000 single visits every month, and is able to offer a solid marketplace, built up over the years, where artists and buyers can meet. Now, the technological leadership of YourArt and the major advances it has made in artificial intelligence can be put to use by all artists and users of the platform. The same goes for its know-how in matters of content (curation by art experts, publications, videos, social media…) and its ability to provide its artists with visibility beyond the digital platform, by means of visits to galleries, exhibitions and meetings.
With artificial intelligence at its core, ArtMajeur by YourArt – one of the foremost online art platforms in the world – provides a unique service for artists and art lovers. Its AI assistant –Iris – was developed by its R&D staff and has specific dedicated features:
For artists, Your Creation is one of the first applications to draw on the new APIs for image generation. It enables artists to generate images from prompts and reference images they themselves have chosen. The results are aimed at stimulating the creative process and may be used by the artists in any way they wish. Also, Your Assistant enables them to use AI to enrich the creative process: by importing the image of a work of art, they can obtain immediate responses (opinions, references, advice…).
For art lovers, Your Gift (finding a suitable work of art), Your Portrait (finding out about one's artistic tastes) and Your Match (presenting a coup de cœur) provide easy access to the whole database. They make it possible for art lovers to choose the works that best correspond to their own tastes from among the thousands of works of art on the platform.
Furthermore, there is a new section on the platform called 'AI & Art.' This details the AI features and also presents how ArtMajeur by YourArt sees the place of AI in art. It lays out its ethical convictions and looks at the current debate on this important and sensitive issue.
Over the next few months, ArtMajeur by YourArt will be adding to the AI features, thereby developing the platform even further, providing more opportunities for art lovers to discover works of art, and increasing sales for artists.
ArtMajeur by YourArt: the key figures
A major platform
3.5 million works of art, 137,000 artists, 750 galleries.
Recent sales: the top 3
47,800€ for Floris mit Frosch und EI by Jean Lawa.
13,965€ for two works by Viktor Sheleg.
12,680€ for Lovely Seal by Irena Aizen.
AI data
90.4% of reactions to all the tests carried out have been positive.
71.9% of users find the analyses, descriptions and suggestions relevant.
Users come from 40 different countries.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
43 minutes ago
- Business Wire
Poxel Provides Update on Negotiations with Creditors and Announces Filing of Reorganization Proceedings, Upcoming Change of Corporate Governance and Suspension of Trading
LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and rare metabolic disorders, today provides an update on its ongoing negotiations with its creditors and its agreement with its senior creditor, IPF Partners, to file for insolvency (déclaration de cessation des paiements), to request the opening of reorganization proceedings (redressement judiciaire) and to undertake significant corporate governance changes in a short notice. Context Failure at the Combined Shareholders' Meeting of February 11, 2025 to approve certain financial delegations, and, in particular, on the issuance of new shares in redemption for bonds redeemable into new or existing shares (ORANE) held, or to be potentially issued and held by IRIS, triggered an event of default under the IRIS and IPF Partners bond financing agreements allowing each of them to request mandatory redemption of the bonds they hold (EUR 4.3 million and EUR 14.2 million, respectively, as of June 30, 2025). Since then, Poxel's Board and Management have actively engaged in restructuring discussions with creditors to identify a solution that would allow the Company to continue its operations. At the same time, the Company pursued discussions with several potential partners for the development of its pipeline. In particular, Poxel entered into advanced negotiations with a prospective partner for PXL065. However, given the short cash runway of the Company (which the Company announced on June 30, 2025 to run through the course of July 2025) as well as the foreseeable timeframe required to close this partnership and sale, this plan could not be completed. As a result, Poxel Management and Board of Directors have agreed to proceed with the following significant structural corporate changes at Poxel, following the filing for insolvency (déclaration de cessation des paiements) and requesting the opening of reorganization proceedings (redressement judiciaire) with the Court for Economic Activities of Lyon. Estimated Consolidated Cash and Cash Equivalents Position as of June 30, 2025 The Company estimates that its total consolidated cash and cash equivalents as of June 30, 2025, amounted to approximately EUR 1.3 million (unaudited), including EUR 563 thousand corresponding to cash held in security trusts bank accounts to secure their financing for several years, in accordance with the royalty monetization agreement with OrbiMed. Filing for insolvency (déclaration de cessation des paiements) and for the opening of reorganization proceedings (redressement judiciaire) On July 29, 2025, Poxel filed for insolvency (déclaration de cessation des paiements) and for the opening of reorganization proceedings (redressement judiciaire) with the Court for Economic Activities of Lyon. A decision of the court is expected to occur on or after the hearing scheduled on August 5, 2025. Impact on Governance and Organization Given the inability to secure support from creditors for its strategic development plan, an agreement between the Board of Directors of Poxel and its senior creditor IPF Partners has been reached to implement the following measures: Replacement of all the current Board members following their individual resignation by new directors coopted by the Board of Directors in a short notice after the filing for the opening of reorganization proceedings (redressement judiciaire) in front of the Court for Economic Activities of Lyon. Appointment of a new transition CEO by the new Board of Directors to occur in a short notice after the filing for the opening of reorganization proceedings (redressement judiciaire) in front of the Court for Economic Activities of Lyon. Implementation of a short-term financial and operational transition plan aimed at ensuring the continuity of Poxel's operations. Existing CEO Thomas Kuhn will provide support to the Company during this transition period. The Board of Directors of the Company has approved the agreement with IPF Partners which is summarized herein and on the website of the Company under the related party transactions (conventions réglementées) subsections. Outlook and 2024 annual accounts Implementation of the steps of the proposed transition plan will be announced as soon as effective, including the change of Governance and the decision of the Court for Economic Activities of Lyon regarding the request for the opening of reorganization proceedings (redressement judiciaire). Given the current situation, the Company is unable to provide an effective timeline for the approval and publication of its 2024 annual report or the convening of its next Annual General Meeting, which has been postponed as mentioned below. Suspension of trading Poxel's shares will be suspended from trading starting July 30, 2025, before market opening and will trade again after the decision of the Court for Economic Activities of Lyon expected to occur on August 5, 2025, or shortly after. Poxel will continue to inform the market of the next major steps of its reorganization proceedings. Postponement of Annual General Meeting until December 31, 2025 As already made public on June 30, 2025, the Lyon Court for Economic Activities granted the Company's request to postpone until December 31, 2025, at the latest, the holding of its 2025 Annual General Meeting due to the delay in the approval of its annual statutory and consolidated financial statements for the fiscal year 2024. As a reminder, this delay in the closing and publication of its 2024 annual results resulted from the potential impact of the negotiations with the Company's financial creditors and with potential partners for the development of the Company's pipeline on its financial statements. The holding of the 2025 Annual General Meeting remains subject to the approval by the Board of Directors of the financial statements for the year ended December 31, 2024. About Poxel SA Poxel is a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and rare disorders. For the treatment of MASH, PXL065 (deuterium-stabilized R -pioglitazone) met its primary endpoint in a streamlined Phase 2 trial (DESTINY-1). In rare diseases, development of PXL770, a first-in-class direct adenosine monophosphate-activated protein kinase (AMPK) activator, is focused on the treatment of adrenoleukodystrophy (ALD) and autosomal dominant polycystic kidney disease (ADPKD). TWYMEEG ® (Imeglimin), Poxel's first-in-class product that targets mitochondrial dysfunction, is now marketed for the treatment of type 2 diabetes in Japan by Sumitomo Pharma and Poxel expects to receive royalties and sales-based payments. Poxel has a strategic partnership with Sumitomo Pharma for Imeglimin in Japan. Listed on Euronext Paris, Poxel is headquartered in Lyon, France, and has subsidiaries in Boston, MA, and Tokyo, Japan. For more information, please visit: All statements other than statements of historical fact included in this press release about future events are subject to (i) change without notice and (ii) factors beyond the Company's control. These statements may include, without limitation, any statements preceded by, followed by or including words such as 'target,' 'believe,' 'expect,' 'aim,' 'intend,' 'may,' 'anticipate,' 'estimate,' 'plan,' 'project,' 'will,' 'can have,' 'likely,' 'should,' 'would,' 'could' and other words and terms of similar meaning or the negative thereof. Forward-looking statements are subject to inherent risks and uncertainties beyond the Company's control that could cause the Company's actual results or performance to be materially different from the expected results or performance expressed or implied by such forward-looking statements. The Company does not endorse or is not otherwise responsible for the content of external hyperlinks referred to in this press release.


The Verge
4 days ago
- The Verge
Google's Pixel Watch 4 should match its new phones.
Posted Jul 25, 2025 at 7:55 AM UTC Google's Pixel Watch 4 should match its new phones. Yesterday we learned Google's new smartwatch might charge on its side, and now Android Headlines has shared official renders of it in various colors, matching almost every hue we've seen from the Pixel 10 phones: the vibrant 'Indigo' and 'Limoncello;' the muted 'Moonstone' and 'Porcelain;' and 'Obsidian' black — plus a return for the Pixel 9A's 'Iris' purple. More colors are expected, while the watch itself will apparently come in black, silver, gold, and 'Moonstone.' 1/6 This punchy 'Limoncello' Sport Band will match the base Pixel 10. Image: Android Headlines Follow topics and authors from this story to see more like this in your personalized homepage feed and to receive email updates. Dominic Preston Posts from this author will be added to your daily email digest and your homepage feed. See All by Dominic Preston Posts from this topic will be added to your daily email digest and your homepage feed. See All Gadgets Posts from this topic will be added to your daily email digest and your homepage feed. See All Google Posts from this topic will be added to your daily email digest and your homepage feed. See All Google Pixel Posts from this topic will be added to your daily email digest and your homepage feed. See All News Posts from this topic will be added to your daily email digest and your homepage feed. See All Smartwatch Posts from this topic will be added to your daily email digest and your homepage feed. See All Tech Posts from this topic will be added to your daily email digest and your homepage feed. See All Wearable


Business Wire
5 days ago
- Business Wire
Viant Launches IRIS-enabled™ Content Report and Pre-Bid Targeting
IRVINE, Calif.--(BUSINESS WIRE)-- Viant Technology Inc. (NASDAQ: DSP), a leader in CTV and AI-powered programmatic advertising, today announced a major advancement with IRIS-enabled™ Content Report and Pre-Bid Targeting within the Viant Demand-Side Platform (DSP). This strategic integration marks a significant milestone for Connected TV (CTV) advertising, delivering on Viant's vision to reduce friction and enhance buyer experiences by seamlessly unifying holistic measurement and targeting directly within the DSP. " is a key ingredient of Viant's overall CTV offering, enabling us to deliver unmatched transparency and targeting precision," said Tim Vanderhook, Co-Founder and CEO of Viant. Exclusive to Viant DSP, the IRIS-enabled Content Report offers advertisers real-time insights into how their ads perform across various contextual and emotional content categories, equipping them with precise, actionable campaign intelligence. For the first time, buyers can instantly compare KPIs such as conversion and video-completion rates to identify which categories and placements drive superior outcomes, eliminating guesswork and offering the clarity to make meaningful optimizations while campaigns are still live. By utilizing the Pre-Bid Targeting feature in tandem with the IRIS-enabled Content Report, advertisers are empowered to turn these insights into action. High-performing contextual and emotional categories surfaced by the report can be instantly applied as video-level targets within the Viant DSP, improving relevance and performance in CTV campaigns. Paired with the scale and addressability of Viant's identity graph and Household ID, advertisers can confidently align their messaging with the right audience at the most impactful moment in the customer journey. " is a key ingredient of Viant's overall CTV offering, enabling us to deliver unmatched transparency and targeting precision," said Tim Vanderhook, Co-Founder and CEO of Viant. "Our integration of IRIS-enabled data significantly enhances campaign effectiveness, demonstrating our ongoing commitment to deliver superior outcomes for advertisers." Eye-tracking research shows that viewers are 4X more likely to tune out ads not relevant to the content they are watching; contextual CTV targeting has been proven to keep viewers engaged by reaching them when they are in the right mindset. Recent data from Upwave highlights the significant efficiency and effectiveness of IRIS-enabled contextual targeting in CTV. Campaigns using IRIS-enabled data demonstrated a 2x lift in awareness, a 3x lift in ad recall, and a remarkable 5x lift in favorability compared to standard Upwave CTV benchmarks, underscoring the power of contextual alignment in driving deep viewer engagement and measurable outcomes. "This launch marks an important milestone in the advancement of contextual targeting in the streaming ecosystem," said Field Garthwaite, CEO of "By combining IRIS-enabled Content Report and Pre-Bid Targeting with Viant's powerful DSP capabilities and leadership in CTV, we're providing advertisers with deeper, actionable insights that drive real-world results." Performance data for the IRIS-enabled content report and pre-bid targeting is available for ads that appear on CTV content assigned an IRIS_ID, proprietary content identifier. Over 75 million videos from the leading streaming platforms are IRIS-enabled, allowing advertisers to choose from a variety content categories provided by content data marketplace partners including 4D, Captify, GumGum, Mobian, Pixability, Reticle, Sightly, Silverpush, SpotRunner and more. ABOUT VIANT Viant Technology Inc. (NASDAQ: DSP) is a leader in AI-powered programmatic advertising, dedicated to driving innovation in digital marketing. Viant's omnichannel platform built for CTV allows marketers to plan, execute and measure their campaigns with unmatched precision and efficiency. With the launch of ViantAI, Viant is building the future of fully autonomous advertising solutions, empowering advertisers to achieve their boldest goals. Viant was recently awarded Best Demand-Side Platform by MarTech Breakthrough, Great Place to Work® certification and received the Business Intelligence Group's AI Excellence Award. Learn more at ABOUT a Viant Technology company, is the leading content data marketplace for streaming. We structure, connect, and activate the world's video-level data to create better viewing experiences and advertising outcomes. Our content identifier, the IRIS_ID, enables our partners to build scalable advertising solutions for contextual, emotional, and brand-suitability planning, targeting, and measurement. Learn more about the IRIS_ID and the IRIS-enabled™ ecosystem of premium sellers, data partners, and ad platforms at